Literature DB >> 19969399

Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis.

Jiaying Sun1, Shaoxi Cai, Ning Yan, Hu Mei.   

Abstract

Surflex-Dock is employed to investigate interactions between neuraminidase inhibitors (NIs) and neuraminidase (NA), which illuminate that carboxyl group, amino (guanidino) group, amide group, hydroxy group are crucial. Hydrogen bonds and hydrophobic interactions impact on activities of NIs. There is a strong correlation between binding affinity and pIC(50), with r=0.813. We have developed three-dimensional holographic vector of atomic interaction field analysis (HoVAIFA) as a new method of 3D-QSAR to understand chemical-biological interactions. Good results, R(2)=0.789 and R(2)cv=0.732, show that HoVAIFA can be applicable to molecular structural characterization and bioactivity prediction. Electrostatic, steric and hydrophobic interactions affect activities of NIs. HoVAIFA and docking results are corresponding, which illustrates that HoVAIFA is an effective methodology for characterization of complex interactions of drug molecules. Crown Copyright (c) 2009. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969399     DOI: 10.1016/j.ejmech.2009.11.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

1.  3D-QSAR and molecular docking studies of azaindole derivatives as Aurora B kinase inhibitors.

Authors:  Ping Lan; Wan-Na Chen; Ping-Hua Sun; Wei-Min Chen
Journal:  J Mol Model       Date:  2010-08-11       Impact factor: 1.810

2.  Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Authors:  Komal Kalani; Dharmendra Kumar Yadav; Feroz Khan; Santosh K Srivastava; Nitasha Suri
Journal:  J Mol Model       Date:  2012-01-21       Impact factor: 1.810

3.  Molecular-level simulation of pandemic influenza glycoproteins.

Authors:  Rommie E Amaro; Wilfred W Li
Journal:  Methods Mol Biol       Date:  2012

4.  Molecular docking and 3D-QSAR study on 4-(1H-indazol-4-yl) phenylamino and aminopyrazolopyridine urea derivatives as kinase insert domain receptor (KDR) inhibitors.

Authors:  Xiaoyun Wu; Shuguang Wu; Wen-Hua Chen
Journal:  J Mol Model       Date:  2011-06-22       Impact factor: 1.810

5.  3D-QSAR and molecular docking studies on fused pyrazoles as p38α mitogen-activated protein kinase inhibitors.

Authors:  Ping Lan; Zhi-Jian Huang; Jun-Rong Sun; Wei-Min Chen
Journal:  Int J Mol Sci       Date:  2010-09-17       Impact factor: 5.923

6.  Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.

Authors:  Yong Ai; Shao-Teng Wang; Ping-Hua Sun; Fa-Jun Song
Journal:  Int J Mol Sci       Date:  2010-09-28       Impact factor: 5.923

7.  Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors.

Authors:  Yuanxin Tian; Jian Xu; Zhonghuang Li; Zhengguang Zhu; Jiajie Zhang; Shuguang Wu
Journal:  Int J Mol Sci       Date:  2011-08-10       Impact factor: 5.923

8.  Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors.

Authors:  Yong Ai; Shao-Teng Wang; Ping-Hua Sun; Fa-Jun Song
Journal:  Int J Mol Sci       Date:  2011-03-01       Impact factor: 5.923

9.  Pyrrolo[3,2-d]pyrimidine derivatives as type II kinase insert domain receptor (KDR) inhibitors: CoMFA and CoMSIA studies.

Authors:  Xiao-Yun Wu; Wen-Hua Chen; Shu-Guang Wu; Yuan-Xin Tian; Jia-Jie Zhang
Journal:  Int J Mol Sci       Date:  2012-02-22       Impact factor: 6.208

10.  Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay.

Authors:  Maywan Hariono; Nurshariza Abdullah; K V Damodaran; Ezatul E Kamarulzaman; Nornisah Mohamed; Sharifah Syed Hassan; Shaharum Shamsuddin; Habibah A Wahab
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.